During the COVID-19 pandemic, pharmaceutical sales reps have been forced to navigate the virtual playing field, and as they operate in this new territory, their confidence is wavering.

We hear from three industry thought leaders who share their insights regarding the importance of championing diversity as well as their vision for pharma’s future.

How can pharma better engage with male patients and encourage them to become more proactive when it comes to looking after their own health?

With a focus on open channels of communication, pharma and the NHS have the potential not just to survive, but to truly thrive.

Achieving equal and accurate representation in clinical trials has long been a challenge for the pharmaceutical industry. We have made great progress towards the goal of patient inclusivity, but what more can be done to ensure that all patient groups are adequately represented and how can digital help to achieve this?

Mace Rothenberg, Chief Medical Officer, Pfizer, speaks to us about his sustained passion for advancing the field of oncology, the importance of diverse representation in patient groups, and the challenges of balancing lifespan with health span.

How ‘recession-proof’ is pharma, and what challenges has COVID-19 posed to this famously robust industry?

How can the pharmaceutical industry and, in particular, medical affairs teams, take pragmatic approaches to combat and curb antimicrobial resistance?